IntelGenx Technologies Corp (IGXT)

[BioSpecialist]

hi there

the $150 million was an estimate by ceo which he did i think 2 years ago but at that time there was no patent deal with eli lilly so maybe the sales potential is much much higher now . Partnership for Tadalafil could happen anytime now then we will know what IGXT will get of milestones and royalties .
---

http://s2.q4cdn.com/790425727/files/doc_financials/2017/Q1/final-051117-intelgenx-corp-q1-2017-financial-results-18899915.pdf

Some of the ANDA applicants have already settled with Lilly, settled in the sense that they have greed to launch their generic product only at the expiry of this third patent, the dosing patent that we obtained a license for. That means that we have a pretty good chance to enjoy an extended period of excessivity once we’ve launched our product. Several companies have expressed interest in licensing the product. Term sheets(phon)have been submitted and are currently being reviewed and the due-diligence process has commenced.